Seer (SEER) Interest & Investment Income (2020 - 2026)
Seer (SEER) posted quarterly Interest & Investment Income of $2.2 million for Q1 2026, down 30.84% year-over-year from $3.2 million in Q1 2025, and down 12.68% quarter-over-quarter from $2.5 million in Q4 2025.
Seer (SEER) Interest & Investment Income (2020 - 2026) Analysis & Trends
Seer's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 30.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $10.5 million (down 31.16% YoY), while the FY2025 annual figure was $11.5 million, down 30.87% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.2 million, down from $2.5 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.8 million in Q3 2023, with the low at $144000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.2 million (2025), against an average of $3.1 million.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 2693.48% in 2022, then tumbled 32.51% in 2025.
- Seer's Interest & Investment Income stood at $2.5 million in 2022, then jumped by 89.03% to $4.7 million in 2023, then declined by 24.47% to $3.6 million in 2024, then retreated by 28.53% to $2.5 million in 2025, then slipped by 12.68% to $2.2 million in 2026.
- Business Quant data shows SEER's Interest & Investment Income at $2.2 million in Q1 2026, $2.5 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 4.77 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 676,000.00 |
| Mar 31, 2022 | 144,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 46,000.00 |